Yüklüyor......
Extracellular Vesicles Act as Nano-Transporters of Tyrosine Kinase Inhibitors to Revert Iodine Avidity in Thyroid Cancer
A new approach for using extracellular vesicles (EVs) to deliver tyrosine kinase inhibitors (TKIs) to enhance iodine avidity in radioactive iodine-refractory thyroid cancer is needed. We isolated and characterized primary human adipose-derived stem cells (ADSCs) and isolated their EVs. The EVs were...
Kaydedildi:
| Yayımlandı: | Pharmaceutics |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
MDPI
2021
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7916551/ https://ncbi.nlm.nih.gov/pubmed/33578882 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics13020248 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|